Bill Search

  • Introduced
    Feb 03, 2021
  • Passed House
    Mar 02, 2022
  • Passed Senate
  • Signed into Law
HB 60
Ohio House Bill
Did you know we offer free bill tracking in Congress and 50 states, and a great mobile app? Sign up here
Authorize medical marijuana for autism spectrum disorder
Last Action See all actions
Senate • Mar 16, 2022: Refer to Committee (Health)
Do you support this bill?
Yay Nay

Official Summary/Bill Text

Comments on HB 60

Tiffany Carwile wrote 1 year ago

Many qualifying conditions for medical cannabis treatment in Ohio, are common symptoms and conditions that coincide closely with Autism. So why are we shoving dangerous pills at children? No pharmaceutical can safely or effectively treat the core symptoms of ASD. Antipsychotics, Risperidone & Aripiprazole (Abilify) are the only two medications that are FDA approved to treat irritability in ASD. Individuals with ASD are often prescribed a variety of antidepressants, anxiolytics, antipsychotics, benzodiazepines as well as stimulants in off-label, untested combinations to treat a myriad of symptoms. These drugs have serious side effects & when given in combination, risk of harm increases significantly. We need to look at what we can do to improve the quality of life for people with autism in Ohio. The cost of not doing so is at the expense of our kids. We must urge those in the medical community, as well as the general population, to change how they observe & treat autism. This a very definite statement of how we treat autistic people and their families. How can cannabis treat a complex condition like Autism? The key is in the endocannabinoid system, which represents a network of lipid signaling pathways. Regulating many, or all, that are dysregulated in ASD, adequate for helping core symptoms. Improvements are a result of the medicinal effects of cannabis on the underlying medical conditions of autism. Research from Stanford University shows that children with ASD have lower plasma levels of anandamide. Anandamide is the Endocannabinoid that mimics THC in the body & plays a role in learning, memory, social functioning, easing anxiety etc. Due to the role of the ECS system, also the documented deficit of anandamide in found in those diagnosed, it is entirely possible that organic cannabinoid-rich extracts from cannabis could be used as agents to target the pathology of Autism Spectrum Disorder. As well as many debilitating symptoms associated with it. I believe that families & physicians should have the authorized right to explore these options without fear of legal repercussions, despite one's age or severity of Autism Spectrum diagnosis. -Tiffany Carwile ***Please email in support of HB60***


Whip Lists

  • Mar 16, 2022 | Senate
    • Refer to Committee (Health)
  • Mar 08, 2022 | Senate
    • Introduced
  • Mar 02, 2022 | House
    • Passed
  • Jan 26, 2022 | House
    • Reported (Health)
  • Feb 04, 2021 | House
    • Refer to Committee (Health)
  • Feb 03, 2021 | House
    • Introduced